Market Access
Medicines pricing, UK £20 notes with various pills

Buyer’s remorse: The UK’s VPAG

With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.

Sales & Marketing

Digital

Digital
12 Questions with Sam Dixey
Sponsored

12 Questions with Sam Dixey

Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Patients

Patients
PSP services
Sponsored

Designing global PSPs for the real world

How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.

R&D